12:00 AM
 | 
Jul 02, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Zonegran regulatory update

Eisai said Russia's Ministry of Health and Social Development approved Zonegran zonisamide as an adjunctive therapy for partial seizures in adults with epilepsy. The pharma, which markets the drug...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >